Systematic review of the clinical effectiveness and cost-effectiveness, and economic evaluation, of denosumab for the treatment of bone metastases from solid tumours
Tools
Ford, J, Cummins, E, Sharma, P, Elders, A, Stewart, F, Johnston, R, Royle, P, Jones, R, Mulatero, C, Todd, R and Mowatt, G (2013) Systematic review of the clinical effectiveness and cost-effectiveness, and economic evaluation, of denosumab for the treatment of bone metastases from solid tumours. Health Technology Assessment, 17 (29). pp. 1-386. ISSN 1366-5278
Full text not available from this repository. (Request a copy)Abstract
Denosumab offers an alternative, or additional, treatment for the prevention of skeletal-related events (SREs) in patients with bone metastases from solid tumours.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | antibodies, monoclonal, humanized,bone density conservation agents,bone neoplasms,breast neoplasms,cost-benefit analysis,female,humans,lung neoplasms,male,models, economic,prostatic neoplasms,quality-adjusted life years,randomized controlled trials as topic |
Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School Faculty of Science > School of Chemistry |
Depositing User: | Pure Connector |
Date Deposited: | 12 Nov 2014 16:50 |
Last Modified: | 06 May 2022 01:28 |
URI: | https://ueaeprints.uea.ac.uk/id/eprint/50668 |
DOI: | 10.3310/hta17290 |
Actions (login required)
![]() |
View Item |